Wakefield Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wakefield Asset Management's LLY Position: Q4 2024 in Review
Wakefield Asset Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 4,247 shares — an estimated $3.76M sold.
Wakefield Asset Management first reported a position in LLY in Q4 2018 and held it in 3 quarters. The position peaked at $3.82M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Wakefield Asset Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
- Wakefield Asset Management sold 4,247 Eli Lilly shares in Q4 2024, an estimated $3.76M.
- Wakefield Asset Management first reported a position in Eli Lilly in Q4 2018 and held it in 3 quarters.
- Wakefield Asset Management's Eli Lilly position peaked at $3.82M in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Wakefield Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.